Browsing by Author "Artaç, Mehmet"

Now showing items 1-2 of 2

Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: a real-life data of Turkish oncology group

Gürbüz, Mustafa; Bilici, Ahmet; Karadurmuş, Nuri; Sezer, Ahmet; Şendur, Mehmet Ali Nahit; Paydaş, Semra; Artaç, Mehmet; Fulden Yumuk, Perran; Gürsoy, Pinar; Uysal, Mükremin; Şenol Coşkun, Hasan; Kilickap, Saadettin (Lippincott Williams and Wilkins, 2022)

Crizotinib is a multikinase inhibitor, effective in non-small cell lung cancer (NSCLC) harboring mesenchymal-epidermal transition (MET) alterations. Although small prospective studies showed efficacy and safety of crizotinib ...
The relationship between plexin C1 overexpression and survival in hepatocellular carcinoma: a Turkish oncology group (TOG) study

Turhal, Serdar Nazım; Doğan, Mutlu; Esendağlı, Güldal; Artaç, Mehmet; Korkmaz, Levent; Çoşkun, Hasan Şenol; Göker, Erdem (Springer, 2021)

Purpose Plexin C1 is a transmembrane receptor and plexin C1 overexpression might have role in carcinogenesis. Hepatocellular carcinoma (HCC) has poor prognosis because of its aggressive behavior and limited treatment ...